Literature DB >> 22003109

Computerized repeating and averaging improve the test-retest variability of ETDRS visual acuity measurements: implications for sensitivity and specificity.

Nilpa Shah1, D Alistair H Laidlaw, Shaheen P Shah, Selvaraj Sivasubramaniam, Catey Bunce, Simon Cousens.   

Abstract

PURPOSE: The goals of this study were to investigate the effectiveness of computerized repeating and averaging of visual acuity measurements in reducing test-retest variability (TRV) and to estimate the increase in sensitivity and specificity that would be achieved in diagnosing visual acuity change.
METHODS: Timed, paired ETDRS chart and computerized acuity mean measurement (CAMM) were performed in 100 subjects. CAMM(n) scores were the running mean of consecutive measurements. Bland-Altman methods were used to calculate 95% ranges for TRV.
RESULTS: The 95% TRV range of ETDRS measurements and the CAMM score after 6 (CAMM6) measurements were, respectively, 8 and 5.7 ETDRS letters (P = 0.02). CAMM6 offered a pragmatically optimum tradeoff between reduced TRV and test time. A measured change of 5 letters or more in the absence of true change was observed in 13% (95% CI, 8%-21%) with the ETDRS chart and 4% (95% CI, 2%-10%) with CAMM6 measurements. To achieve ≥95% test sensitivity (assuming 95% test specificity), change criteria of 15 and 11 letters must be set with an ETDRS chart and CAMM6, respectively. CAMM6 measurement times were longer (mean 234 seconds vs. 74 seconds) for the ETDRS chart.
CONCLUSIONS: Compared with the current gold standard, computerized repeating and averaging of acuity measurements improve specificity and sensitivity when identifying true changes. The 160-second increase in test time should be set against the considerable economic and clinical benefits that may result.

Mesh:

Year:  2011        PMID: 22003109     DOI: 10.1167/iovs.11-7797

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  The influence of varying the number of characters per row on the accuracy and reproducibility of the ETDRS visual acuity chart.

Authors:  Reuben R Shamir; Yael G Friedman; Leo Joskowicz; Michael Mimouni; Eytan Z Blumenthal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-07       Impact factor: 3.117

2.  Rapid and reliable assessment of the contrast sensitivity function on an iPad.

Authors:  Michael Dorr; Luis A Lesmes; Zhong-Lin Lu; Peter J Bex
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-05       Impact factor: 4.799

3.  LogMAR and Stereoacuity in Keratoconus Corrected with Spectacles and Rigid Gas-permeable Contact Lenses.

Authors:  Vinay Kumar Nilagiri; Sangeetha Metlapally; Parthasarathi Kalaiselvan; Clifton M Schor; Shrikant R Bharadwaj
Journal:  Optom Vis Sci       Date:  2018-04       Impact factor: 1.973

4.  Comparison of Snellen and Early Treatment Diabetic Retinopathy Study charts using a computer simulation.

Authors:  Reuben R Shamir; Yael Friedman; Leo Joskowicz; Michael Mimouni; Eytan Z Blumenthal
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

5.  An assessment of the iPad as a testing platform for distance visual acuity in adults.

Authors:  J M Black; R J Jacobs; G Phillips; L Chen; E Tan; A Tran; B Thompson
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

6.  Psychophysical Validation of a Novel Active Learning Approach for Measuring the Visual Acuity Behavioral Function.

Authors:  Yukai Zhao; Luis Andres Lesmes; Michael Dorr; Peter J Bex; Zhong-Lin Lu
Journal:  Transl Vis Sci Technol       Date:  2021-01-04       Impact factor: 3.283

7.  Do Black and Asian individuals wait longer for treatment? A survival analysis investigating the effect of ethnicity on time-to-clinic and time-to-treatment for diabetic eye disease.

Authors:  Varo Kirthi; Kate I Reed; Ramith Gunawardena; Komeil Alattar; Catey Bunce; Timothy L Jackson
Journal:  Diabetologia       Date:  2021-01-26       Impact factor: 10.122

8.  Using a Computerised Staircase and Incremental Optotype Sizes to Improve Visual Acuity Assessment Accuracy.

Authors:  Anna O'Connor; Chloe King; Ashli Milling; Laurence Tidbury
Journal:  Br Ir Orthopt J       Date:  2022-07-20

9.  YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale.

Authors:  Nicole Eter; Rishi P Singh; Francis Abreu; Kemal Asik; Karen Basu; Caroline Baumal; Andrew Chang; Karl G Csaky; Zdenka Haskova; Hugh Lin; Carlos Quezada Ruiz; Paisan Ruamviboonsuk; David Silverman; Charles C Wykoff; Jeffrey R Willis
Journal:  Ophthalmol Sci       Date:  2021-12-30

10.  Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema.

Authors:  Andrew J Lloyd; Jane Loftus; Michelle Turner; Ginny Lai; Andreas Pleil
Journal:  Health Qual Life Outcomes       Date:  2013-01-24       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.